MN-18
MN-18[edit | edit source]
MN-18 is a synthetic cannabinoid that has been used in scientific research. It is a potent agonist of the cannabinoid receptors, which are part of the endocannabinoid system in the human body. MN-18 is structurally related to other synthetic cannabinoids and is often studied for its effects on the central nervous system.
Chemical Properties[edit | edit source]
MN-18 is classified as an indole-based synthetic cannabinoid. Its chemical structure includes a core indole ring, which is a common feature among many synthetic cannabinoids. The specific chemical formula of MN-18 is C23H22N2O, and it has a molecular weight of 342.44 g/mol.
Pharmacology[edit | edit source]
MN-18 acts as a full agonist at the CB1 receptor and CB2 receptor, which are the primary receptors for cannabinoids in the body. These receptors are part of the G protein-coupled receptor family and are involved in a variety of physiological processes, including pain modulation, appetite regulation, and immune response.
The binding affinity of MN-18 to these receptors is high, which contributes to its potent effects. The activation of CB1 receptors by MN-18 can lead to psychoactive effects similar to those produced by tetrahydrocannabinol (THC), the active component of cannabis.
Effects and Uses[edit | edit source]
In research settings, MN-18 is used to study the effects of synthetic cannabinoids on the brain and body. It is often used in animal models to investigate the potential therapeutic and adverse effects of cannabinoid receptor activation.
The effects of MN-18 can include alterations in mood, perception, and cognition, as well as physiological effects such as changes in heart rate and blood pressure. Due to its potency, MN-18 is typically used in very small doses in research studies.
Legal Status[edit | edit source]
The legal status of MN-18 varies by country. In some jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. Researchers working with MN-18 must comply with relevant regulations and obtain appropriate licenses.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
